Author

L. Corey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Organism:human· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

D. Corey· 2 shared J. Zhu· 2 shared A. Arballo· 1 shared A. Bhatta· 1 shared A. Maiti· 1 shared A. Wald· 1 shared A. Z. Li· 1 shared B. Cieniewicz· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Corey

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia

B. Cieniewicz, E. Oliveira, M. Saxton, D. Torabi, A. Bhatta, P. Kukutla, A. Arballo, Z. Yang, B. Yu, M. Fate, H. Ning, L. Corey, A. Maiti, D. Corey

This study identifies TIM-4-L as a novel target for T cell therapy in AML, showing engineered T cells effectively eliminate AML cells in vitro and in vivo.

Clinical Cancer Research · May 1, 2024Peer-reviewedCancer Biology

Novel engineered chimeric engulfment receptors trigger T-cell effector functions against SIV infected CD4+ T cells

D. Corey, F. Haeseleer, L. Corey

This study shows that engineered T cells with chimeric engulfment receptors can kill SIV-infected CD4+ T cells by recognizing phosphatidylserine.

bioRxiv · Jun 21, 2022Immunology

A CAR RNA FISH assay to study functional and spatial heterogeneity of chimeric antigen receptor T cells in tissue

K. Eichholz, A. Z. Li, K. Diem, M. Jensen, J. Zhu, L. Corey

The paper develops a CAR RNA FISH assay to study the trafficking and function of CAR T cells in mouse tissue at single-cell resolution.

bioRxiv · Aug 21, 2020Cancer Biology

Elimination of HSV-2 infected cells is mediated predominantly by paracrine effects of tissue-resident T cell derived cytokines

P. Roychoudhury, D. A. Swan, E. Duke, L. Corey, J. Zhu, V. Dave, L. Richert Spuhler, J. M. Lund, M. Prlic, J. Schiffer

The paper shows HSV-2 is controlled by cytokines from tissue-resident T cells, not direct cell killing, even when T-cell numbers are low.

bioRxiv · Apr 18, 2019 · PreprintImmunology

Increased oral Epstein-Barr virus shedding with HIV-1 co-infection is due to a combination of B cell activation and impaired cellular immune control

C. M. Byrne, C. Johnson, J. Orem, F. Okuku, M.-L. Huang, S. Selke, A. Wald, L. Corey, J. T. Schiffer, C. Casper, D. Coombs, S. Gantt

This study finds that HIV-1 co-infection increases oral EBV shedding due to B cell activation and weakened cellular immune control, validated through mathematical modeling.

bioRxiv · Mar 24, 2019 · PreprintPathology